Rosacea treatment update: recommendations from the global ROS acea CO nsensus ( ROSCO ) panel
Open Access
- 12 November 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 176 (2) , 465-471
Abstract
Background Rosacea is currently treated according to subtypes. As this does not adequately address the spectrum of clinical presentation (phenotypes), it has implications for patient management. The ROSacea COnsensus panel was established to address this issue. Objectives To incorporate current best treatment evidence with clinical experience from an international expert panel and establish consensus to improve outcomes for patients with rosacea. Methods Seventeen dermatologists and three ophthalmologists reached consensus on critical aspects of rosacea treatment and management using a modified Delphi approach. The panel voted on statements using the responses ‘strongly disagree’, ‘disagree’, ‘agree’ or ‘strongly agree’. Consensus was defined as ≥ 75% ‘agree’ or ‘strongly agree’. All voting was electronic and blinded. Results The panel agreed on phenotype‐based treatments for signs and symptoms presenting in individuals with rosacea. First‐line treatments were identified for individual major features of transient and persistent erythema, inflammatory papules/pustules, telangiectasia and phyma, underpinned by general skincare measures. Multiple features in an individual patient can be simultaneously treated with multiple agents. If treatment is inadequate given appropriate duration, another first‐line option or the addition of another first‐line agent should be considered. Maintenance treatment depends on treatment modality and patient preferences. Ophthalmological referral for all but the mildest ocular features should be considered. Lid hygiene and artificial tears in addition to medications are used to treat ocular rosacea. Conclusions Rosacea diagnosis and treatment should be based on clinical presentation. Consensus was achieved to support this approach for rosacea treatment strategies.Keywords
Funding Information
- Galderma
This publication has 24 references indexed in Scilit:
- Expert Consensus on Best Practices for Post–Acute Rehabilitation After Total Hip and Knee Arthroplasty: A Canada and United States Delphi StudyArthritis Care & Research, 2014
- Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adultsNeurology, 2012
- Rosacea – global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert GroupJournal of the European Academy of Dermatology and Venereology, 2011
- EFNS guideline on the drug treatment of migraine – revised report of an EFNS task forceEuropean Journal of Neurology, 2009
- Going from evidence to recommendationsBMJ, 2008
- What is “quality of evidence” and why is it important to clinicians?BMJ, 2008
- Status Report on Antibiotic Resistance: Implications for the DermatologistDermatologic Clinics, 2007
- Dysfunctional Tear SyndromeCornea, 2006
- An evidence and consensus based guideline for acute diarrhoea managementArchives of Disease in Childhood, 2001
- Qualitative Research: Consensus methods for medical and health services researchBMJ, 1995